Mirum Pharmaceuticals, Inc. (MIRM)
USD 40.6
(-4.81%)
USD 40.6
(-4.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 186.37 Million | 77.06 Million | 19.13 Million | - | - | - |
| Cost of Revenue | 47.03 Million | 12.37 Million | 1.9 Million | 623 Thousand | 324 Thousand | - |
| Gross Profit | 139.33 Million | 64.68 Million | 17.23 Million | -623 Thousand | -324 Thousand | - |
| Operating Expenses | 248.48 Million | 195.9 Million | 190.64 Million | 104.29 Million | 54.74 Million | 2.91 Million |
| Selling, General and Administrative Expenses | 145.88 Million | 89.06 Million | 59.22 Million | 22.69 Million | 11.75 Million | 585 Thousand |
| Research and Development Expenses | 102.6 Million | 106.84 Million | 131.42 Million | 81.6 Million | 42.99 Million | 2.33 Million |
| Other Expenses | - | 365 Thousand | 107.41 Million | -192 Thousand | -21 Thousand | - |
| Cost and Expenses | 295.52 Million | 208.28 Million | 192.55 Million | 104.29 Million | 54.74 Million | 2.91 Million |
| Operating Income | -109.15 Million | -131.22 Million | -173.41 Million | -104.29 Million | -54.74 Million | -2.91 Million |
| Interest Expense | 15.1 Million | 15.97 Million | 17.59 Million | 335 Thousand | - | - |
| Income Tax Expense | 991 Thousand | -6.4 Million | 37 Thousand | 6000.00 | 21 Thousand | -4.37 Million |
| Earnings before Tax | -162.42 Million | -142.07 Million | -83.95 Million | -103.26 Million | -52.53 Million | -17.34 Million |
| Net Income | -163.41 Million | -135.66 Million | -83.98 Million | -103.27 Million | -52.55 Million | -17.34 Million |
| Earnings Per Share Basic | -4.00 | -4.01 | -2.77 | -4.09 | -2.29 | -0.75 |
| Earnings Per Share Diluted | -4.00 | -4.01 | -2.77 | -4.09 | -2.29 | -0.75 |
| Weighted Average Shares Outstanding | 40.88 Million | 33.83 Million | 30.32 Million | 25.25 Million | 22.98 Million | 22.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.88 Million | 33.83 Million | 30.32 Million | 25.25 Million | 22.98 Million | 22.98 Million |
| Gross Margin | 0.75 | 0.84 | 0.90 | - | - | - |
| EBIT Margin | -0.73 | -1.65 | -3.38 | - | - | - |
| Profit Margin | -0.88 | -1.76 | -4.39 | - | - | - |
| EBITDA | -136.49 Million | -122.41 Million | -65.38 Million | -102.3 Million | -52.2 Million | -17.33 Million |
| Earnings Before Tax Margin | -0.59 | -1.70 | -9.06 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 77.87 Million | 69.22 Million | 186.37 Million | 69.55 Million | 47.72 Million | 37.49 Million |
| Cost of Revenue | 20.38 Million | 17.83 Million | 47.36 Million | 22.6 Million | 10.22 Million | 6.81 Million |
| Gross Profit | 57.49 Million | 51.39 Million | 139 Million | 46.95 Million | 37.49 Million | 30.68 Million |
| Operating Expenses | 81.72 Million | 77.86 Million | 248.16 Million | 77.02 Million | 62.64 Million | 54.95 Million |
| Selling, General and Administrative Expenses | 49.2 Million | 45.63 Million | - | 46.18 Million | 36.52 Million | 32.94 Million |
| Research and Development Expenses | 32.51 Million | 32.22 Million | - | 30.84 Million | 26.11 Million | 22 Million |
| Other Expenses | 312 Thousand | 1.75 Million | -2.82 Million | 46.01 Million | 1.32 Million | -49.35 Million |
| Cost and Expenses | 102.1 Million | 95.69 Million | 295.52 Million | 99.62 Million | 72.87 Million | 61.77 Million |
| Operating Income | -24.23 Million | -26.46 Million | -109.15 Million | -30.07 Million | -25.14 Million | -24.27 Million |
| Interest Expense | 3.56 Million | 3.57 Million | 15.1 Million | 3.56 Million | -3.57 Million | 3.72 Million |
| Income Tax Expense | 635 Thousand | 624 Thousand | 991 Thousand | 225 Thousand | 249 Thousand | 316 Thousand |
| Earnings before Tax | -24 Million | -24.65 Million | -162.42 Million | -32.92 Million | -23.33 Million | -73.72 Million |
| Net Income | -24.63 Million | -25.27 Million | -163.41 Million | -33.14 Million | -23.58 Million | -74.03 Million |
| Earnings Per Share Basic | -0.52 | -0.54 | - | -0.71 | -0.57 | -1.94 |
| Earnings Per Share Diluted | -0.52 | -0.54 | - | -0.71 | -0.57 | -1.94 |
| Weighted Average Shares Outstanding | 47.23 Million | 46.92 Million | 40.88 Million | 46.72 Million | 41.09 Million | 38.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 47.23 Million | 46.92 Million | 40.88 Million | 46.72 Million | 41.09 Million | 38.1 Million |
| Gross Margin | 0.74 | 0.74 | 0.75 | 0.68 | 0.79 | 0.82 |
| EBIT Margin | -0.24 | -0.22 | - | -0.35 | -0.53 | -1.87 |
| Profit Margin | -0.32 | -0.37 | -0.88 | -0.48 | -0.49 | -1.97 |
| EBITDA | -18.37 Million | -15.41 Million | - | -24.67 Million | -25.14 Million | -69.99 Million |
| Earnings Before Tax Margin | -0.31 | -0.38 | -0.59 | -0.43 | -0.53 | -0.65 |
VRNO
KLRFM
GUJPETR
BXRDF
HUMX
SAGA